Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | ADH1B | P00325 | 1/20 | 0.42 |
| ▸ | ADH1C | P00326 | 1/20 | 0.42 |
| ▸ | ADH1A | P07327 | 1/20 | 0.42 |
| ▸ | ADH4 | P08319 | 1/20 | 0.42 |
| ▸ | ADH7 | P40394 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 2/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 2/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3335405 | 1.00 | TSHR (0.42) | TSHRADH1BADH1CADH1AADH4 | |
| SCHEMBL2712523 | 1.00 | TSHR (0.42) | TSHRADH1BADH1CADH1AADH4 | |
| SCHEMBL14759069 | 1.00 | TSHR (0.42) | TSHRADH1BADH1CADH1AADH4 | |
| SCHEMBL8868706 | 1.00 | TSHR (0.42) | TSHRADH1BADH1CADH1AADH4 | |
| SCHEMBL1130661 | 0.98 | ADH1B (0.39) | TSHRADH1BADH1CADH1AADH4 | |
| SCHEMBL7923014 | 0.91 | ADH1B (0.47) | TSHRADH1BADH1CADH1AADH4 | |
| SCHEMBL8411738 | 0.91 | ADH1B (0.47) | TSHRADH1BADH1CADH1AADH4 | |
| SCHEMBL9579563 | 0.91 | ADH1B (0.47) | TSHRADH1BADH1CADH1AADH4 | |
| SCHEMBL19252728 | 0.91 | ADH1B (0.47) | TSHRADH1BADH1CADH1AADH4 | |
| SCHEMBL2690910 | 0.91 | TSHR (0.42) | TSHRADH1BADH1CADH1AADH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130131239-A1 | Method for Producing Mixtures of Alkylphosphonous Acid Salts And Dialkylphosphinic Acid Salts | CLARIANT FINANCE (BVI) LIMITED (VG) | 2013-05-23 | — | — | US | claimed |
| EP-2563797-A2 | METHOD FOR PRODUCING MIXTURES OF ALKYLPHOSPHONOUS ACID SALTS AND DIALKYLPHOSPHINIC ACID SALTS | Clariant Finance (BVI) Limited (VG) | 2013-03-06 | — | — | EP | claimed |
| CN-102250094-A | 2-alkylthio-9-alcoxyalkyl adenine compound and synthesis thereof | UNIV BEIJING CHEMICAL | 2011-11-23 | — | — | CN | claimed |
| WO-2011134620-A2 | METHOD FOR PRODUCING MIXTURES OF ALKYLPHOSPHONOUS ACID SALTS AND DIALKYLPHOSPHINIC ACID SALTS | CLARIANT INTERNATIONAL LTD (CH) | 2011-11-03 | — | — | WO | claimed |
| EP-1308541-A1 | Plating bath and method for depositing a metal layer on a substrate | Shipley Company LLC (US) | 2003-05-07 | — | — | EP | claimed |
| US-20030066756-A1 | Plating bath and method for depositing a metal layer on a substrate | SHIPLEY COMPANY, L.L.C. | 2003-04-10 | — | — | US | claimed |
| CN-111465593-B | Novel compound, photopolymerization initiator containing the same, and photosensitive resin composition containing the photopolymerization initiator | 日本化药株式会社 | 2023-06-23 | — | — | CN | disclosed |
| CN-112552173-B | Preparation method of fluoro alkenyl ketone compound | 山东领海生物科技有限公司 | 2022-11-15 | — | — | CN | disclosed |
| WO-2021009311-A1 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS | SYNGENTA CROP PROTECTION AG (CH) | 2021-01-21 | — | — | WO | disclosed |
| US-10716795-B2 | Steroid analogues for neuroprotection | EMORY UNIVERSITY (US) | 2020-07-21 | — | — | US | disclosed |
| US-10239856-B2 | Synthesis of resorcylic acid lactones useful as therapeutic agents | UNIVERSITY DE STRASBOURG (FR) | 2019-03-26 | — | — | US | disclosed |
| US-20180221390-A1 | Steroid Analogues for Neuroprotection | UNIV EMORY (US) | 2018-08-09 | — | — | US | disclosed |
| US-20170174669-A1 | POCHOXIME CONJUGATES USEFUL FOR THE TREATMENT OF HSP90 RELATED PATHOLOGIES | UNIV STRASBOURG (FR) | 2017-06-22 | — | — | US | disclosed |
| CN-1034501-C | (Bemzhydryloxyethylpiperidyl) aliphatic acid derivatives and their use in the treatment of allergies and asthma | SANKYO CO (JP) | 1997-04-09 | — | — | CN | disclosed |
| US-5102793-A | STEREOSPECIFIC KETO REDUCTION OF BICYCLOOCTANDIONE-CARBOXYLIC ACID ESTERS BY MICROORGANISMS | SCHERING AKTIENGESELLSCHAFT (DE) | 1992-04-07 | — | — | US | disclosed |
| CN-1051178-A | New heterogeneous ring compound and preparation method thereof | YAMANOUCHI PHARMA CO LTD (JP) | 1991-05-08 | — | — | CN | disclosed |
| US-4918107-A | HYDROXYPHENYLACETYL-L-ASPARAGINYL COMPOUNDS | TSUMURA & CO. (JP) | 1990-04-17 | — | — | US | disclosed |
| US-4288361-A | ANTIOXIDANTS FOR POLYMERS | CARSTAB CORPORATION (US) | 1981-09-08 | — | — | US | disclosed |
| US-4205176-A | ANTIOXIDANTS | CINCINNATI MILACRON CHEMICALS INC. (US) | 1980-05-27 | — | — | US | disclosed |
| US-3976700-A | FROM ACETONE AND PRENYL CHLORIDE, ALKALI METAL HYDROXIDE, NITROGEN CONTAINING CATALYST | RHODIA, INC. (US) | 1976-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170174669-A1 | POCHOXIME CONJUGATES USEFUL FOR THE TREATMENT OF HSP90 RELATED PATHOLOGIES | HSP90AB2P, HSP90AB1, HSP90AA1 | TSHR 3852/4885ADH1B 4474/4885ADH1C 2942/4885 |
| US-20180221390-A1 | Steroid Analogues for Neuroprotection | CYP11A1, NR3C2, HSD17B7 | TSHR 2481/4885ADH1B 1168/4885ADH1C 1245/4885 |
| US-10239856-B2 | Synthesis of resorcylic acid lactones useful as therapeutic agents | HSP90AA1, HSP90AB1, HSP90AB2P | TSHR 3246/4885ADH1B 3556/4885ADH1C 3442/4885 |
| US-10716795-B2 | Steroid analogues for neuroprotection | CYP11A1, NR3C2, HSD17B7 | TSHR 2481/4885ADH1B 1168/4885ADH1C 1245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.